Polychlorinated biphenyls (
PCBs) are
persistent organic pollutants associated with
non-alcoholic fatty liver disease (
NAFLD) in epidemiologic studies. The purpose of this study was to evaluate the hepatic effects of a PCB mixture,
Aroclor 1260, whose composition mimics human bioaccumulation patterns, in a mouse model of diet-induced
obesity (DIO). Male C57Bl/6J mice were fed control diet or 42% high fat diet (HFD) and exposed to
Aroclor 1260 (20mg/kg or 200mg/kg in
corn oil) for 12weeks. A
glucose tolerance test was performed; plasma/tissues were obtained at necropsy for measurements of
adipocytokine levels, histology, and gene expression.
Aroclor 1260 exposure was associated with decreased body fat in HFD-fed mice but had no effect on
blood glucose/
lipid levels. Paradoxically,
Aroclor 1260+HFD co-exposed mice demonstrated increased hepatic inflammatory foci at both doses while the degree of steatosis did not change. Serum
cytokines, ALT levels and hepatic expression of
IL-6 and TNFα were increased only at 20mg/kg, suggesting an inhibition of pro-inflammatory
cytokine production at the 200mg/kg exposure.
Aroclor 1260 induced hepatic expression of
cytochrome P450s including Cyp3a11 (Pregnane-
Xenobiotic Receptor target) and Cyp2b10 (
constitutive androstane receptor target) but Cyp2b10 inducibility was diminished with HFD-feeding.
Cyp1a2 (
aryl hydrocarbon Receptor target) was induced only at 200mg/kg. In summary,
Aroclor 1260 worsened hepatic and systemic
inflammation in DIO. The results indicated a bimodal response of PCB-diet interactions in the context of
inflammation which could potentially be explained by
xenobiotic receptor activation. Thus, PCB exposure may be a relevant "second hit" in the transformation of steatosis to
steatohepatitis.